Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.21.2
Equity Incentive Plan (Tables)
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense
   

Three Months Ended
September 30,

(unaudited)

    

Nine Months Ended
September 30,

(unaudited)

  
(in thousands)   2021     2020     2021     2020  
General and administrative   $ 258     $ 69     $ 649     $ 359  
Sales and marketing     31       18       88       70  
Research and development     68       9       181       48  
Cost of revenues     14       3       76       14  
    $ 371     $ 99     $ 994     $ 491  

  
Schedule of fair value of option grants weighted average assumptions
   

Nine Months Ended
September 30,

(unaudited)

  
    2021     2020  
Expected term (in years)     5.8       5.0  
Expected Volatility     54.4 %     38.1 %
Risk-free rate     0.8 %     0.5 %
Dividend rate    
—
      
—
  

 
Schedule of stock option activity
   

Number of

Shares under

Option Plan

     Weighted-
Average
Exercise
Price per
Option		    

Weighted-

Average

Remaining

Contractual

Life (in years)

  
Outstanding at December 31, 2020     4,211,857     $ 0.76       8.6  
Granted     2,642,172     $ 3.16          
Exercised     (180,405 )   $ 0.82          
Forfeited and expired     (99,301 )   $ 1.65          
Outstanding at September 30, 2021     6,574,323     $ 1.71       8.2  
Exercisable at September 30, 2021     3,312,725     $ 0.99       8.0  
Vested and expected to vest at September 30, 2021     6,164,089     $ 1.62       8.4